164 related articles for article (PubMed ID: 14583488)
1. Identification and characterization of an inhibitor of eukaryotic elongation factor 2 kinase against human cancer cell lines.
Arora S; Yang JM; Kinzy TG; Utsumi R; Okamoto T; Kitayama T; Ortiz PA; Hait WN
Cancer Res; 2003 Oct; 63(20):6894-9. PubMed ID: 14583488
[TBL] [Abstract][Full Text] [Related]
2. Investigating the kinetic mechanism of inhibition of elongation factor 2 kinase by NH125: evidence of a common in vitro artifact.
Devkota AK; Tavares CD; Warthaka M; Abramczyk O; Marshall KD; Kaoud TS; Gorgulu K; Ozpolat B; Dalby KN
Biochemistry; 2012 Mar; 51(10):2100-12. PubMed ID: 22352903
[TBL] [Abstract][Full Text] [Related]
3. P-glycoprotein mediates resistance to histidine kinase inhibitors.
Arora S; Yang JM; Utsumi R; Okamoto T; Kitayama T; Hait WN
Mol Pharmacol; 2004 Sep; 66(3):460-7. PubMed ID: 15322237
[TBL] [Abstract][Full Text] [Related]
4. Novel compounds, '1,3-selenazine derivatives' as specific inhibitors of eukaryotic elongation factor-2 kinase.
Cho SI; Koketsu M; Ishihara H; Matsushita M; Nairn AC; Fukazawa H; Uehara Y
Biochim Biophys Acta; 2000 Jul; 1475(3):207-15. PubMed ID: 10913818
[TBL] [Abstract][Full Text] [Related]
5. Inhibiting eEF-2 kinase-mediated autophagy enhanced the cytocidal effect of AKT inhibitor on human nasopharyngeal carcinoma.
Zhao YY; Tian Y; Liu L; Zhan JH; Hou X; Chen X; Zhou T; Huang Y; Zhang L
Drug Des Devel Ther; 2018; 12():2655-2663. PubMed ID: 30214154
[TBL] [Abstract][Full Text] [Related]
6. Identification of the ubiquitin-proteasome pathway in the regulation of the stability of eukaryotic elongation factor-2 kinase.
Arora S; Yang JM; Hait WN
Cancer Res; 2005 May; 65(9):3806-10. PubMed ID: 15867377
[TBL] [Abstract][Full Text] [Related]
7. Detection of anti-elongation factor 2 kinase (calmodulin-dependent protein kinase III) antibodies in patients with systemic lupus erythematosus.
Arora S; Yang JM; Craft J; Hait W
Biochem Biophys Res Commun; 2002 May; 293(3):1073-6. PubMed ID: 12051769
[TBL] [Abstract][Full Text] [Related]
8. Regulation of translation elongation factor-2 by insulin via a rapamycin-sensitive signalling pathway.
Redpath NT; Foulstone EJ; Proud CG
EMBO J; 1996 May; 15(9):2291-7. PubMed ID: 8641294
[TBL] [Abstract][Full Text] [Related]
9. Elongation factor-2 kinase regulates autophagy in human glioblastoma cells.
Wu H; Yang JM; Jin S; Zhang H; Hait WN
Cancer Res; 2006 Mar; 66(6):3015-23. PubMed ID: 16540650
[TBL] [Abstract][Full Text] [Related]
10. Regulation of protein-synthesis elongation-factor-2 kinase by cAMP in adipocytes.
Diggle TA; Redpath NT; Heesom KJ; Denton RM
Biochem J; 1998 Dec; 336 ( Pt 3)(Pt 3):525-9. PubMed ID: 9841860
[TBL] [Abstract][Full Text] [Related]
11. Mapping the functional domains of elongation factor-2 kinase.
Pavur KS; Petrov AN; Ryazanov AG
Biochemistry; 2000 Oct; 39(40):12216-24. PubMed ID: 11015200
[TBL] [Abstract][Full Text] [Related]
12. Elongation factor-2 kinase: its role in protein synthesis and autophagy.
Hait WN; Wu H; Jin S; Yang JM
Autophagy; 2006; 2(4):294-6. PubMed ID: 16921268
[TBL] [Abstract][Full Text] [Related]
13. Effect of serum and hydrogen peroxide on the Ca2+/calmodulin-dependent phosphorylation of eukaryotic elongation factor 2(eEF-2) in Chinese hamster ovary cells.
Kang KR; Lee SY
Exp Mol Med; 2001 Dec; 33(4):198-204. PubMed ID: 11795480
[TBL] [Abstract][Full Text] [Related]
14. Elongation factor-2 kinase: effective inhibition by the novel protein kinase inhibitor rottlerin and relative insensitivity towards staurosporine.
Gschwendt M; Kittstein W; Marks F
FEBS Lett; 1994 Jan; 338(1):85-8. PubMed ID: 8307162
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of eukaryotic elongation factor 2 in differentiating and proliferating HL-60 cells.
Nilsson A; Nygård O
Biochim Biophys Acta; 1995 Sep; 1268(3):263-8. PubMed ID: 7548224
[TBL] [Abstract][Full Text] [Related]
16. Effects of rottlerin, an inhibitor of calmodulin-dependent protein kinase III, on cellular proliferation, viability, and cell cycle distribution in malignant glioma cells.
Parmer TG; Ward MD; Hait WN
Cell Growth Differ; 1997 Mar; 8(3):327-34. PubMed ID: 9056675
[TBL] [Abstract][Full Text] [Related]
17. Regulation of elongation factor-2 kinase by pH.
Dorovkov MV; Pavur KS; Petrov AN; Ryazanov AG
Biochemistry; 2002 Nov; 41(45):13444-50. PubMed ID: 12416990
[TBL] [Abstract][Full Text] [Related]
18. 1-Benzyl-3-cetyl-2-methylimidazolium iodide (NH125) induces phosphorylation of eukaryotic elongation factor-2 (eEF2): a cautionary note on the anticancer mechanism of an eEF2 kinase inhibitor.
Chen Z; Gopalakrishnan SM; Bui MH; Soni NB; Warrior U; Johnson EF; Donnelly JB; Glaser KB
J Biol Chem; 2011 Dec; 286(51):43951-43958. PubMed ID: 22020937
[TBL] [Abstract][Full Text] [Related]
19. Structure of the complex between calmodulin and a functional construct of eukaryotic elongation factor 2 kinase bound to an ATP-competitive inhibitor.
Piserchio A; Isiorho EA; Dalby KN; Ghose R
J Biol Chem; 2023 Jun; 299(6):104813. PubMed ID: 37172726
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of the translation elongation factor 2 kinase in Xenopus laevis oocytes at the final stages of oogenesis.
Severinov KV; Melnikova EG; Ryazanov AG
New Biol; 1990 Oct; 2(10):887-93. PubMed ID: 2078557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
